
Comprehensive overview of COVID-19 research by Dr Philip McMillan, focusing on autoimmunity as the primary pathology in the disease.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 646 | Founded | 4 years ago | Last Issue | 7 days ago |
| Active | |||||

I have been taking a closer look at some of the more unusual side effects being reported around Ozempic and related GLP-1 drugs. The reason is simple. I do not think we are living in the same physiological landscape that existed before the...
I was watching a series recently when I realised one of the actors I remembered so clearly was no longer there. That actor was Adan Canto. Many will know him from Designated Survivor, The Cleaning Lady, or X-Men: Days of Future Past. He was...
Toxic liver disease is rising in a way that does not fit a simple "one toxin" explanation.
I have been looking carefully at NHS Hospital Episode Statistics from 2016 to 2025, and one signal has become difficult to ignore.
When I first covered this story, the CDC had delayed publication of internal data suggesting that updated COVID boosters reduced emergency department visits and hospitalisations by around 50 to 55 percent. At the time, I raised a series of...
I have been looking carefully at the recent Paxlovid paper, and what troubles me is not the result itself. It is what the result reveals about the way pandemic medicine was handled.
The paper reports that nirmatrelvir–ritonavir, the drug c...
Subscribers, engagement, traffic and sponsorship for Vejon COVID-19 Review.
| Subscribers | Engagement | 83 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #54 | |
| #37 |
The writers behind this newsletter.
Physician and researcher with an innovative approach to COVID-19 and dementia reversal, international keynote speaker and LinkedIn Live influencer.
You can find recent issues that have been published by Vejon COVID-19 Review on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Vejon COVID-19 Review, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Vejon COVID-19 Review as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Vejon COVID-19 Review using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Vejon COVID-19 Review. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.